{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:39:38Z","timestamp":1783478378347,"version":"3.55.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["Finance Code 001"],"award-info":[{"award-number":["Finance Code 001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s13346-020-00821-5","type":"journal-article","created":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T14:03:25Z","timestamp":1594908205000},"page":"1552-1570","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Development, characterization, and anti-leishmanial activity of topical amphotericin B nanoemulsions"],"prefix":"10.1007","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2691-5335","authenticated-orcid":false,"given":"Ana Paula","family":"dos Santos Matos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deise Cristina Drummond Xavier Paes","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lu\u00edza Hon\u00f3rio","family":"Peixoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"da Silva Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alane Beatriz","family":"Vermelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Santos-Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra Lifsitch","family":"Vi\u00e7osa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Holandino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Ricci-J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,16]]},"reference":[{"key":"821_CR1","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.colsurfb.2013.01.041","volume":"106","author":"TTH Pham","year":"2013","unstructured":"Pham TTH, Barratt G, Michel JP, Loiseau PM, Saint-Pierre-Chazalet M. Interactions of antileishmanial drugs with monolayers of lipids used in the development of amphotericin B-miltefosine-loaded nanocochleates. Colloids Surf B: Biointerfaces. 2013;106:224\u201333.","journal-title":"Colloids Surf B: Biointerfaces"},{"key":"821_CR2","doi-asserted-by":"crossref","first-page":"e525","DOI":"10.1016\/j.ijid.2011.03.021","volume":"15","author":"TS Tiuman","year":"2011","unstructured":"Tiuman TS, Santos AO, Ueda-Nakamura T, Filho BPD, Nakamura CV. Recent advances in leishmaniasis treatment. Int J Infect Dis. 2011;15:e525\u201332.","journal-title":"Int J Infect Dis"},{"key":"821_CR3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S1995-7645(12)60084-4","volume":"5","author":"N Singh","year":"2012","unstructured":"Singh N, Kumar M, Singh RK. Leishmaniasis: current status of available drugs and new potential drug targets. Asian Pac J Trop Med. 2012;5:485\u201397.","journal-title":"Asian Pac J Trop Med"},{"key":"821_CR4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.parint.2007.01.004","volume":"56","author":"DC Soares","year":"2007","unstructured":"Soares DC, Pereira CG, Meireles M\u00c2A, Saraiva EM. Leishmanicidal activity of a supercritical fluid fraction obtained from Tabernaemontana catharinensis. Parasitol Int. 2007;56:135\u20139.","journal-title":"Parasitol Int"},{"key":"821_CR5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10719-006-9014-z","volume":"24","author":"A Dutta","year":"2007","unstructured":"Dutta A, Mandal G, Mandal C, Chatterjee M. In vitro antileishmanial activity of Aloe vera leaf exudate: a potential herbal therapy in leishmaniasis. Glycoconj J. 2007;24:81\u20136.","journal-title":"Glycoconj J"},{"key":"821_CR6","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.tmaid.2014.09.007","volume":"12","author":"P Mansueto","year":"2014","unstructured":"Mansueto P, Seidita A, Vitale G, Cascio A. Leishmaniasis in travelers: a literature review. Travel Med Infect Dis. 2014;12:563\u201381.","journal-title":"Travel Med Infect Dis"},{"key":"821_CR7","doi-asserted-by":"publisher","first-page":"101664","DOI":"10.1016\/j.jddst.2020.101664","volume":"57","author":"APS Matos","year":"2020","unstructured":"Matos APS, Vi\u00e7osa AL, R\u00e9 MI, Ricci-J\u00fanior E, Holandino C. A review of current treatments strategies based on paromomycin for leishmaniasis. J Drug Deliv Sci Technol. 2020;57:101664. Available from:. https:\/\/doi.org\/10.1016\/j.jddst.2020.101664.","journal-title":"J Drug Deliv Sci Technol"},{"key":"821_CR8","unstructured":"World Health Organization. Cutaneous and mucosal leishmaniasis Pan American Health Organization [Internet]. WHO Pan Am. Heal. Organ. 2020. Available from: https:\/\/www.paho.org\/en\/topics\/leishmaniasis\/cutaneous-and-mucosal-leishmaniasis. Accessed May 2020."},{"key":"821_CR9","unstructured":"World Health Organization. Cutaneous leishmaniasis factsheet | Information resources-leishmaniasis | Neglected tropical diseases [Internet]. WHO East. Mediterr. Reg. Off. 2020. Available from: http:\/\/www.emro.who.int\/neglected-tropical-diseases\/information-resources-leishmaniasis\/cl-factsheet.html. Accessed May 2020."},{"key":"821_CR10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s40506-015-0038-4","volume":"7","author":"DP Eiras","year":"2015","unstructured":"Eiras DP, Kirkman LA, Murray HW. Cutaneous leishmaniasis: current treatment practices in the USA for returning travelers. Curr Treat Options Infect Dis. 2015;7:52\u201362.","journal-title":"Curr Treat Options Infect Dis"},{"key":"821_CR11","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.2174\/1381612825666190705202030","volume":"25","author":"GMF Ara\u00fajo","year":"2019","unstructured":"Ara\u00fajo GMF, Barros ARA, Oshiro-Junior JA, Soares LF, da Rocha LG, de Lima \u00c1AN, et al. Nanoemulsions loaded with amphotericin B: development, characterization and leishmanicidal activity. Curr Pharm Des. 2019;25:1616\u201322.","journal-title":"Curr Pharm Des"},{"key":"821_CR12","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.ijpharm.2013.05.044","volume":"454","author":"AE Silva","year":"2013","unstructured":"Silva AE, Barratt G, Ch\u00e9ron M, Egito EST. Development of oil-in-water microemulsions for the oral delivery of amphotericin B. Int J Pharm. 2013;454:641\u20138.","journal-title":"Int J Pharm"},{"key":"821_CR13","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/jac\/dkz049","volume":"74","author":"LF Neira","year":"2019","unstructured":"Neira LF, Mantilla JC, Escobar P. Anti-leishmanial activity of a topical miltefosine gel in experimental models of New World cutaneous leishmaniasis. J Antimicrob Chemother. 2019;74:1634\u201341.","journal-title":"J Antimicrob Chemother"},{"key":"821_CR14","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jconrel.2012.05.037","volume":"161","author":"H Van De Ven","year":"2012","unstructured":"Van De Ven H, Paulussen C, Feijens PB, Matheeussen A, Rombaut P, Kayaert P, et al. PLGA nanoparticles and nanosuspensions with amphotericin B: potent in vitro and in vivo alternatives to Fungizone and AmBisome. J Control Release. 2012;161:795\u2013803.","journal-title":"J Control Release"},{"key":"821_CR15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.colsurfb.2014.01.014","volume":"116","author":"D Butani","year":"2014","unstructured":"Butani D, Yewale C, Misra A. Amphotericin B topical microemulsion : formulation , characterization and evaluation. Colloids Surf B: Biointerfaces. 2014;116:351\u20138.","journal-title":"Colloids Surf B: Biointerfaces"},{"key":"821_CR16","unstructured":"The International Pharmacopoeia - Ninth Edition - World Health Organization. Amphotericin B (Amphotericinum B) Monograph. 2019;1\u20132."},{"key":"821_CR17","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1166\/jbn.2012.1385","volume":"8","author":"CM Santos","year":"2012","unstructured":"Santos CM, De Oliveira RB, Arantes VT, Caldeira LR, De Oliveira MC, Egito EST, et al. Amphotericin B-loaded nanocarriers for topical treatment of cutaneous leishmaniasis : development , characterization , and in vitro skin permeation studies. J Biomed Nanotechnol. 2012;8:322\u20139.","journal-title":"J Biomed Nanotechnol"},{"key":"821_CR18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejps.2015.01.015","volume":"70","author":"LR Caldeira","year":"2015","unstructured":"Caldeira LR, Fernandes FR, Costa DF, Fr\u00e9zard F, Afonso LCC, Ferreira LAM. Nanoemulsions loaded with amphotericin B : a new approach for the treatment of leishmaniasis. Eur J Pharm Sci. 2015;70:125\u201331.","journal-title":"Eur J Pharm Sci"},{"key":"821_CR19","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.drudis.2017.06.004","volume":"22","author":"B Zulfiqar","year":"2017","unstructured":"Zulfiqar B, Shelper TB, Avery VM. Leishmaniasis drug discovery: recent progress and challenges in assay development. Drug Discov Today. 2017;22:1516\u201331.","journal-title":"Drug Discov Today"},{"key":"821_CR20","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.addr.2012.02.005","volume":"64","author":"CL Stevenson","year":"2012","unstructured":"Stevenson CL, Santini JT, Langer R. Reservoir-based drug delivery systems utilizing microtechnology. Adv Drug Deliv Rev. 2012;64:1590\u2013602.","journal-title":"Adv Drug Deliv Rev"},{"key":"821_CR21","doi-asserted-by":"crossref","unstructured":"Dowling AP. Development of nanotechnologies. Nanotoday. 2004:30\u20135.","DOI":"10.1016\/S1369-7021(04)00628-5"},{"key":"821_CR22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1773-2247(13)50016-5","volume":"23","author":"R Herrero-Vanrell","year":"2013","unstructured":"Herrero-Vanrell R, Vicario De La Torre M, Andr\u00e9s-Guerrero V, Barbosa-Alfaro D, Molina-Mart\u00ednez IT, Bravo-Osuna I. Nano and microtechnologies for ophthalmic administration, an overview. J Drug Deliv Sci Technol. 2013;23:75\u2013102.","journal-title":"J Drug Deliv Sci Technol"},{"key":"821_CR23","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.addr.2012.11.005","volume":"65","author":"L Mei","year":"2013","unstructured":"Mei L, Zhang Z, Zhao L, Huang L, Yang X, Tang J, et al. Pharmaceutical nanotechnology for oral delivery of anticancer drugs. Adv Drug Deliv Rev. 2013;65:880\u201390.","journal-title":"Adv Drug Deliv Rev"},{"key":"821_CR24","first-page":"e01822","volume":"62","author":"ADJ Sousa-batista","year":"2018","unstructured":"Sousa-batista ADJ, Pacienza-lima W, Arruda-costa N, Bandeira A, R\u00e9 MI, Rossi-bergmann B. Depot subcutaneous injection with chalcone CH8-loaded poly(lactic-co-glycolic acid) microspheres as a single-dose treatment of cutaneous Leishmaniasis. Antimicrob Agents Chemother. 2018;62:e01822\u201317.","journal-title":"Antimicrob Agents Chemother"},{"key":"821_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2007.08.001","volume":"69","author":"M Gaumet","year":"2008","unstructured":"Gaumet M, Vargas A, Gurny R, Delie F. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. Eur J Pharm Biopharm. 2008;69:1\u20139.","journal-title":"Eur J Pharm Biopharm"},{"key":"821_CR26","doi-asserted-by":"crossref","unstructured":"Kheawfu K, Pikulkaew S, Rades T, M\u00fcllertz A, Okonogi S. Development and characterization of clove oil nanoemulsions and self-microemulsifying drug delivery systems. J Drug Deliv Sci Technol. 2018;46:330\u20138.","DOI":"10.1016\/j.jddst.2018.05.028"},{"key":"821_CR27","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1039\/C2SM06903B","volume":"8","author":"DJ McClements","year":"2012","unstructured":"McClements DJ. Nanoemulsions versus microemulsions: terminology, differences, and similarities. Soft Matter. 2012;8:1719\u201329.","journal-title":"Soft Matter"},{"key":"821_CR28","doi-asserted-by":"crossref","first-page":"123709","DOI":"10.1016\/j.colsurfa.2019.123709","volume":"579","author":"GT Vladisavljevi\u0107","year":"2019","unstructured":"Vladisavljevi\u0107 GT. Preparation of microemulsions and nanoemulsions by membrane emulsification. Colloids Surf A Physicochem Eng Asp. 2019;579:123709.","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"key":"821_CR29","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ijpharm.2017.05.005","volume":"526","author":"SP Callender","year":"2017","unstructured":"Callender SP, Mathews JA, Kobernyk K, Wettig SD. Microemulsion utility in pharmaceuticals: implications for multi-drug delivery. Int J Pharm. 2017;526:425\u201342.","journal-title":"Int J Pharm"},{"key":"821_CR30","doi-asserted-by":"crossref","first-page":"425101","DOI":"10.1088\/1361-6528\/ab30c1","volume":"30","author":"L Betzler De Oliveira De Siqueira","year":"2019","unstructured":"Betzler De Oliveira De Siqueira L, Matos APDS, Cardoso VDS, Villanova JCO, Guimar\u00e3es BDCLR, Dos Santos EP, et al. Clove oil nanoemulsion showed potent inhibitory effect against Candida spp. Nanotechnology. 2019;30:425101.","journal-title":"Nanotechnology"},{"key":"821_CR31","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jconrel.2017.11.049","volume":"270","author":"VK Rai","year":"2018","unstructured":"Rai VK, Mishra N, Yadav KS, Yadav NP. Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery : formulation development , stability issues , basic considerations and applications. J Control Release. 2018;270:203\u201325.","journal-title":"J Control Release"},{"key":"821_CR32","doi-asserted-by":"crossref","unstructured":"Singh Y, Meher JG, Raval K, Khan FA, Chaurasia M, Jain NK, et al. Nanoemulsion: concepts, development and applications in drug delivery. J Control Release. 2017;252:28\u201349.","DOI":"10.1016\/j.jconrel.2017.03.008"},{"key":"821_CR33","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/j.nano.2017.06.021","volume":"13","author":"L Sosa","year":"2017","unstructured":"Sosa L, Clares B, Alvarado HL, Bozal N, Domenech O, Calpena AC. Amphotericin B releasing topical nanoemulsion for the treatment of candidiasis and aspergillosis. Nanomed Nanotechnol Biol Med. 2017;13:2303\u201312.","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"821_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cofs.2017.06.003","volume":"16","author":"JM Montes de Oca-\u00c1valos","year":"2017","unstructured":"Montes de Oca-\u00c1valos JM, Candal RJ, Herrera ML. Nanoemulsions: stability and physical properties. Curr Opin Food Sci. 2017;16:1\u20136.","journal-title":"Curr Opin Food Sci"},{"key":"821_CR35","first-page":"1","volume":"6","author":"VV Halnor","year":"2018","unstructured":"Halnor VV, Pande VV, Borawake DD, Nagare HS. Nanoemulsion : a novel platform for drug delivery system. J Mater Sci Nanotechnol. 2018;6:1\u201311.","journal-title":"J Mater Sci Nanotechnol"},{"key":"821_CR36","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1166\/jnn.2015.9187","volume":"15","author":"\u00c9N Alencar","year":"2015","unstructured":"Alencar \u00c9N, Xavier-J\u00fanior FH, Morais ARV, Dantas TRF, Dantas-Santos N, Verissimo LM, et al. Chemical characterization and antimicrobial activity evaluation of natural oil nanostructured emulsions. J Nanosci Nanotechnol. 2015;15:880\u20138.","journal-title":"J Nanosci Nanotechnol"},{"key":"821_CR37","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.xphs.2017.03.042","volume":"106","author":"H Choudhury","year":"2017","unstructured":"Choudhury H, Gorain B, Pandey M, Chatterjee LA, Sengupta P, Das A, et al. Recent update on nanoemulgel as topical drug delivery system. J Pharm Sci. 2017;106:1736\u201351.","journal-title":"J Pharm Sci"},{"key":"821_CR38","doi-asserted-by":"crossref","unstructured":"Sengupta P, Chatterjee B. Potential and future scope of nanoemulgel formulation for topical delivery of lipophilic drugs. Int J Pharm. 2017;526:353\u201365.","DOI":"10.1016\/j.ijpharm.2017.04.068"},{"key":"821_CR39","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/medicines3040025","volume":"3","author":"W Dhifi","year":"2016","unstructured":"Dhifi W, Bellili S, Jazi S, Bahloul N, Mnif W. Essential oils\u2019 chemical characterization and investigation of some biological activities: a critical review. Medicines. 2016;3:25.","journal-title":"Medicines."},{"key":"821_CR40","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ejmech.2018.01.046","volume":"146","author":"RR Teixeira","year":"2018","unstructured":"Teixeira RR, Vaz BG, Bergmann BR, Ferreira RS, Vasconcelos GA, Lima WP, et al. Synthesis and leishmanicidal activity of eugenol derivatives bearing 1,2,3-triazole functionalities. Eur J Med Chem. 2018;146:274\u201386.","journal-title":"Eur J Med Chem"},{"key":"821_CR41","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jfoodeng.2017.05.006","volume":"212","author":"M Sharma","year":"2017","unstructured":"Sharma M, Mann B, Sharma R, Bajaj R, Athira S, Sarkar P, et al. Sodium caseinate stabilized clove oil nanoemulsion: physicochemical properties. J Food Eng. 2017;212:38\u201346.","journal-title":"J Food Eng"},{"key":"821_CR42","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1016\/j.arabjc.2015.08.024","volume":"12","author":"MH Shahavi","year":"2019","unstructured":"Shahavi MH, Hosseini M, Jahanshahi M, Meyer RL, Darzi GN. Evaluation of critical parameters for preparation of stable clove oil nanoemulsion. Arab J Chem. 2019;12:3225\u201330.","journal-title":"Arab J Chem"},{"key":"821_CR43","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.1016\/j.bmc.2014.08.020","volume":"22","author":"SM De Morais","year":"2014","unstructured":"De Morais SM, Vila-Nova NS, Bevilaqua CML, Rondon FC, Lobo CH, Moura ADAAN, et al. Thymol and eugenol derivatives as potential antileishmanial agents. Bioorg Med Chem. 2014;22:6250\u20135.","journal-title":"Bioorg Med Chem"},{"key":"821_CR44","doi-asserted-by":"publisher","unstructured":"De Oliveira De Siqueira LB, Da Silva CV, Rodrigues IA, Vazquez-Villa AL, Dos Santos EP, Da Costa Leal Ribeiro Guimar\u00e3es B, et al. Development and evaluation of zinc phthalocyanine nanoemulsions for use in photodynamic therapy for Leishmania spp. Nanotechnology. 2017 [cited 2019 Feb 25];28:1\u201318. Available from:. https:\/\/doi.org\/10.1088\/1361-6528\/28\/6\/065101\/pdf.","DOI":"10.1088\/1361-6528\/28\/6\/065101\/pdf"},{"key":"821_CR45","first-page":"1","volume":"11","author":"VEB Campos","year":"2012","unstructured":"Campos VEB, Ricci-J\u00fanior E, Mansur CRE. Nanoemulsions as delivery systems for lipophilic drugs. J Nanosci Nanotechnol. 2012;11:1\u201311.","journal-title":"J Nanosci Nanotechnol"},{"key":"821_CR46","first-page":"1","volume":"22","author":"ARST Silva","year":"2017","unstructured":"Silva ARST, Scher R, Santos FV, Ferreira SR, Cavalcanti SCH, Correa CB, et al. Leishmanicidal activity and structure-activity relationships of essential oil constituents. Molecules. 2017;22:1\u201310.","journal-title":"Molecules."},{"key":"821_CR47","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1099\/jmm.0.064709-0","volume":"63","author":"M Islamuddin","year":"2014","unstructured":"Islamuddin M, Sahal D, Afrin F. Apoptosis-like death in Leishmania donovani promastigotes induced by eugenol-rich oil of Syzygium aromaticum. J Med Microbiol. 2014;63:74\u201385.","journal-title":"J Med Microbiol"},{"key":"821_CR48","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.parint.2005.10.006","volume":"55","author":"T Ueda-Nakamura","year":"2006","unstructured":"Ueda-Nakamura T, Mendon\u00e7a-Filho RR, Morgado-D\u00edaz JA, Korehisa Maza P, Prado Dias Filho B, Apar\u00edcio Garcia Cortez D, et al. Antileishmanial activity of Eugenol-rich essential oil from Ocimum gratissimum. Parasitol Int. 2006;55:99\u2013105.","journal-title":"Parasitol Int"},{"key":"821_CR49","first-page":"961","volume":"5","author":"VEB de Campos","year":"2010","unstructured":"de Campos VEB, Teixeira CAA, da Veiga VF, Ricci E, Holandino C. L-Tyrosine-loaded nanoparticles increase the antitumoral activity of direct electric current in a metastatic melanoma cell model. Int J Nanomedicine. 2010;5:961\u201371.","journal-title":"Int J Nanomedicine"},{"key":"821_CR50","unstructured":"United States Pharmacopeia (USP 35). Amphotericin B monograph. United States Pharmacop. 2012;2:2206\u20137."},{"key":"821_CR51","first-page":"5529","volume":"10","author":"CB de Mattos","year":"2015","unstructured":"de Mattos CB, Argenta DF, Melchiades G d L, Cordeiro MNS, Tonini ML, Moraes MH, et al. Nanoemulsions containing a synthetic chalcone as an alternative for treating cutaneous leshmaniasis: optimization using a full factorial design. Int J Nanomedicine. 2015;10:5529\u201342.","journal-title":"Int J Nanomedicine"},{"key":"821_CR52","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0378-5173(03)00404-6","volume":"265","author":"H Fukui","year":"2003","unstructured":"Fukui H, Koike T, Saheki A, Sonoke S, Seki J. A novel delivery system for amphotericin B with lipid nano-sphere (LNS\u00ae). Int J Pharm. 2003;265:37\u201345.","journal-title":"Int J Pharm"},{"key":"821_CR53","unstructured":"United States Pharmacopeia (USP 35). Buffer solutions. United States Pharmacop. 2012;1:1067\u20138."},{"key":"821_CR54","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.2147\/IJN.S164404","volume":"13","author":"T Zanela da Silva Marques","year":"2018","unstructured":"Zanela da Silva Marques T, Santos-Oliveira R, De Siqueira LB d O, Da Silva Cardoso V, De Freitas ZMF, Da Silva Ascen\u00e7\u00e3o Barros RDC, et al. Development and characterization of a nanoemulsion containing propranolol for topical delivery. Int J Nanomedicine. 2018;13:2827\u201337.","journal-title":"Int J Nanomedicine"},{"key":"821_CR55","first-page":"1","volume":"53","author":"PDO Arantes","year":"2017","unstructured":"Arantes PDO, Santos QN d, de Freitas ZMF, Pyrrho A d S, Cerqueira-Coutinho C, Villa ALV, et al. Promotion of cutaneous penetration of nifedipine for nanoemulsion. Braz J Pharm Sci. 2017;53:1\u201312.","journal-title":"Braz J Pharm Sci"},{"key":"821_CR56","first-page":"3045","volume":"7","author":"MS d S d B Monteiro","year":"2012","unstructured":"Monteiro MS d S d B, Ozzetti RA, Vergnanini AL, de Brito-Gitirana L, Volpato NM, de Freitas ZMF, et al. Evaluation of octyl p-methoxycinnamate included in liposomes and cyclodextrins in anti-solar preparations: preparations, characterizations and in vitro penetration studies. Int J Nanomedicine. 2012;7:3045\u201358.","journal-title":"Int J Nanomedicine"},{"key":"821_CR57","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1080\/14756366.2018.1463221","volume":"33","author":"CV da Silva","year":"2018","unstructured":"da Silva CV, Vermelho AB, Ricci Junior E, Almeida Rodrigues I, Mazotto AM, Supuran CT. Antileishmanial activity of sulphonamide nanoemulsions targeting the \u03b2-carbonic anhydrase from Leishmania species. J Enzyme Inhib Med Chem. 2018;33:850\u20137.","journal-title":"J Enzyme Inhib Med Chem"},{"key":"821_CR58","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1080\/14756366.2019.1626375","volume":"34","author":"A Nocentini","year":"2019","unstructured":"Nocentini A, Osman SM, Almeida IA, Cardoso V, Alasmary FAS, AlOthman Z, et al. Appraisal of anti-protozoan activity of nitroaromatic benzenesulfonamides inhibiting carbonic anhydrases from Trypanosoma cruzi and Leishmania donovani. J Enzyme Inhib Med Chem. 2019;34:1164\u201371.","journal-title":"J Enzyme Inhib Med Chem"},{"key":"821_CR59","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55\u201363.","journal-title":"J Immunol Methods"},{"key":"821_CR60","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00436-006-0126-y","volume":"99","author":"M Rol\u00f3n","year":"2006","unstructured":"Rol\u00f3n M, Vega C, Escario JA, G\u00f3mez-Barrio A. Development of resazurin microtiter assay for drug sensibility testing of Trypanosoma cruzi epimastigotes. Parasitol Res. 2006;99:103\u20137.","journal-title":"Parasitol Res"},{"key":"821_CR61","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/j.bmcl.2017.03.049","volume":"27","author":"MM Masood","year":"2017","unstructured":"Masood MM, Hasan P, Tabrez S, Ahmad MB, Yadava U, Daniliuc CG, et al. Anti-leishmanial and cytotoxic activities of amino acid-triazole hybrids: synthesis, biological evaluation, molecular docking and in silico physico-chemical properties. Bioorg Med Chem Lett. 2017;27:1886\u201391.","journal-title":"Bioorg Med Chem Lett"},{"key":"821_CR62","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3109\/03639045.2013.771647","volume":"40","author":"A Hussain","year":"2014","unstructured":"Hussain A, Samad A, Nazish I, Ahmed FJ. Nanocarrier-based topical drug delivery for an antifungal drug. Drug Dev Ind Pharm. 2014;40:527\u201341.","journal-title":"Drug Dev Ind Pharm"},{"key":"821_CR63","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/1061186X.2017.1387787","volume":"26","author":"DCM dos Santos","year":"2018","unstructured":"dos Santos DCM, de Souza MLS, Teixeira EM, Alves LL, Vilela JMC, Andrade M, et al. A new nanoemulsion formulation improves antileishmanial activity and reduces toxicity of amphotericin B. J Drug Target. 2018;26:357\u201364.","journal-title":"J Drug Target"},{"key":"821_CR64","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1467-2494.2006.00344.x","volume":"28","author":"H Lambers","year":"2006","unstructured":"Lambers H, Piessens S, Bloem A, Pronk H, Finkel P. Natural skin surface pH is on average below 5, which is beneficial for its resident flora. Int J Cosmet Sci. 2006;28:359\u201370.","journal-title":"Int J Cosmet Sci"},{"key":"821_CR65","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2340\/00015555-1531","volume":"93","author":"SM Ali","year":"2013","unstructured":"Ali SM, Yosipovitch G. Skin pH: from basic science to basic skin care. Acta Derm Venereol. 2013;93:261\u20137.","journal-title":"Acta Derm Venereol"},{"key":"821_CR66","doi-asserted-by":"crossref","first-page":"118460","DOI":"10.1016\/j.ijpharm.2019.118460","volume":"567","author":"VFM Carvalho","year":"2019","unstructured":"Carvalho VFM, Salata GC, de Matos JKR, Costa-Fernandez S, Chorilli M, Steiner AA, et al. Optimization of composition and obtainment parameters of biocompatible nanoemulsions intended for intraductal administration of piplartine (piperlongumine) and mammary tissue targeting. Int J Pharm. 2019;567:118460.","journal-title":"Int J Pharm"},{"key":"821_CR67","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11746-013-2356-3","volume":"91","author":"V Polychniatou","year":"2014","unstructured":"Polychniatou V, Tzia C. Study of formulation and stability of co-surfactant free water-in-olive oil nano- and submicron emulsions with food grade non-ionic surfactants. J Am Oil Chem Soc. 2014;91:79\u201388.","journal-title":"J Am Oil Chem Soc"},{"key":"821_CR68","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ultsonch.2011.07.001","volume":"19","author":"SY Tang","year":"2012","unstructured":"Tang SY, Manickam S, Wei TK, Nashiru B. Formulation development and optimization of a novel Cremophore EL-based nanoemulsion using ultrasound cavitation. Ultrason Sonochem. 2012;19:330\u201345.","journal-title":"Ultrason Sonochem"},{"key":"821_CR69","doi-asserted-by":"crossref","unstructured":"Bonner DP, Mechlinski W, Schaffner CP. Stability studies with Amphotericin B and Amphotericin B methyl ester. J Antibiot. 1975;28(2):132\u20135.","DOI":"10.7164\/antibiotics.28.132"},{"key":"821_CR70","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1128\/AAC.42.4.762","volume":"42","author":"S Walker","year":"1998","unstructured":"Walker S, Tailor SAN, Lee M, Louie L, Louie M, Simor AE. Amphotericin B in lipid emulsion: stability, compatibility, and in vitro antifungal activity. Antimicrob Agents Chemother. 1998;42:762\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"821_CR71","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1590\/S0100-40422008000300024","volume":"31","author":"FB Filippin","year":"2008","unstructured":"Filippin FB, Souza LC, Maranh\u00e3o RC. Amphotericin B associated with triglyceride-rich nanoemulsion: stability studies and in vitro antifungal activity. Quim Nova. 2008;31:591\u20134.","journal-title":"Quim Nova"},{"key":"821_CR72","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.ijbiomac.2017.07.161","volume":"105","author":"PK Singh","year":"2017","unstructured":"Singh PK, Pawar VK, Jaiswal AK, Singh Y, Srikanth CH, Chaurasia M, et al. Chitosan coated pluronicf127 micelles for effective delivery of amphotericin B in experimental visceral leishmaniasis. Int J Biol Macromol. 2017;105:1220\u201331.","journal-title":"Int J Biol Macromol"},{"key":"821_CR73","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.micron.2011.07.014","volume":"43","author":"V Klang","year":"2012","unstructured":"Klang V, Matsko NB, Valenta C, Hofer F. Electron microscopy of nanoemulsions: an essential tool for characterisation and stability assessment. Micron. 2012;43:85\u2013103.","journal-title":"Micron."},{"key":"821_CR74","first-page":"652","volume":"23","author":"A Hussain","year":"2016","unstructured":"Hussain A, Samad A, Singh SK, Ahsan MN, Haque MW, Faruk A, et al. Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation. Drug Deliv. 2016;23:652\u201367.","journal-title":"Drug Deliv"},{"key":"821_CR75","unstructured":"Connors KA, Amidon GL, Stella VJ. Amphotericin B Monograph. Chem Stab Pharm A Handb Pharm. 2nd Ed. John Wiley & Sons, Inc.; 1986. p. 193\u20137."},{"key":"821_CR76","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.3109\/10717544.2016.1153747","volume":"23","author":"A Hussain","year":"2016","unstructured":"Hussain A, Singh VK, Singh OP, Shafaat K, Kumar S, Ahmad FJ. Formulation and optimization of nanoemulsion using antifungal lipid and surfactant for accentuated topical delivery of amphotericin B. Drug Deliv. 2016;23:3101\u201310.","journal-title":"Drug Deliv"},{"key":"821_CR77","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jsps.2014.11.004","volume":"23","author":"BT AL-Quadeib","year":"2015","unstructured":"AL-Quadeib BT, Radwan MA, Siller L, Horrocks B, Wright MC. Stealth amphotericin B nanoparticles for oral drug delivery: in vitro optimization. Saudi Pharm J. 2015;23:290\u2013302.","journal-title":"Saudi Pharm J"},{"key":"821_CR78","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.ijbiomac.2014.10.014","volume":"72","author":"YS Chhonker","year":"2015","unstructured":"Chhonker YS, Prasad YD, Chandasana H, Vishvkarma A, Mitra K, Shukla PK, et al. Amphotericin-B entrapped lecithin\/chitosan nanoparticles for prolonged ocular application. Int J Biol Macromol. 2015;72:1451\u20138.","journal-title":"Int J Biol Macromol"},{"key":"821_CR79","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijpddr.2019.06.001","volume":"11","author":"AJ Sousa-batista","year":"2019","unstructured":"Sousa-batista AJ, Pacienza-lima W, R\u00e9 MI, Rossi-bergmann B. Novel and safe single-dose treatment of cutaneous leishmaniasis with implantable amphotericin B-loaded microparticles. Int J Parasitol Drugs Drug Resist. 2019;11:148\u201355.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"821_CR80","doi-asserted-by":"crossref","unstructured":"Santiago RR, Gyselle de Holan da e Silva K, Dantas dos Santos N, Genre J, Freitas de Oliveira Lione V, Silva AL, et al. Nanostructured lipid carriers containing amphotericin B: development, in vitro release assay, and storage stability. J Drug Deliv Sci Technol. 2018;48:372\u201382.","DOI":"10.1016\/j.jddst.2018.10.003"},{"key":"821_CR81","doi-asserted-by":"crossref","first-page":"118900","DOI":"10.1016\/j.ijpharm.2019.118900","volume":"573","author":"MJ Dar","year":"2020","unstructured":"Dar MJ, Khalid S, McElroy CA, Satoskar AR, Khan GM. Topical treatment of cutaneous leishmaniasis with novel amphotericin B-miltefosine co-incorporated second generation ultra-deformable liposomes. Int J Pharm. 2020;573:118900.","journal-title":"Int J Pharm"},{"key":"821_CR82","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.colsurfb.2015.12.003","volume":"139","author":"AP Perez","year":"2016","unstructured":"Perez AP, Altube MJ, Schilrreff P, Apezteguia G, Celes FS, Zacchino S, et al. Topical amphotericin B in ultradeformable liposomes: formulation, skin penetration study, antifungal and antileishmanial activity in vitro. Colloids Surf B: Biointerfaces. 2016;139:190\u20138.","journal-title":"Colloids Surf B: Biointerfaces"},{"key":"821_CR83","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2184.2006.00384.x","volume":"39","author":"A Prashar","year":"2006","unstructured":"Prashar A, Locke IC, Evans CS. Cytotoxicity of clove (Syzygium aromaticum) oil and its major components to human skin cells. Cell Prolif. 2006;39:241\u20138.","journal-title":"Cell Prolif"},{"key":"821_CR84","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s13213-010-0092-6","volume":"60","author":"B Kouidhi","year":"2010","unstructured":"Kouidhi B, Zmantar T, Bakhrouf A. Anticariogenic and cytotoxic activity of clove essential oil (Eugenia caryophyllata) against a large number of oral pathogens. Ann Microbiol. 2010;60:599\u2013604.","journal-title":"Ann Microbiol"},{"key":"821_CR85","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.exppara.2016.07.005","volume":"169","author":"DVC Mendon\u00e7a","year":"2016","unstructured":"Mendon\u00e7a DVC, Lage LMR, Lage DP, Ch\u00e1vez-Fumagalli MA, Ludolf F, Roatt BM, et al. Poloxamer 407 (Pluronic F127)-based polymeric micelles for amphotericin B : in vitro biological activity, toxicity and in vivo therapeutic efficacy against murine tegumentary leishmaniasis. Exp Parasitol. 2016;169:34\u201342.","journal-title":"Exp Parasitol"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-020-00821-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-020-00821-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-020-00821-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T23:54:43Z","timestamp":1626393283000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-020-00821-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,16]]},"references-count":85,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["821"],"URL":"https:\/\/doi.org\/10.1007\/s13346-020-00821-5","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,16]]},"assertion":[{"value":"16 July 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}